Correlation Between Agios Pharm and Akero Therapeutics

Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Agios Pharm and Akero Therapeutics, you can compare the effects of market volatilities on Agios Pharm and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Akero Therapeutics.

Diversification Opportunities for Agios Pharm and Akero Therapeutics

0.55

Correlation Coefficient

Agios Pharm  Akero Therapeutics

Very weak diversification

The 3 months correlation between Agios and Akero is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Agios Pharm i.e., Agios Pharm and Akero Therapeutics go up and down completely randomly.

Pair Corralation between Agios Pharm and Akero Therapeutics

Given the investment horizon of 90 days Agios Pharm is expected to under-perform the Akero Therapeutics. In addition to that, Agios Pharm is 1.38 times more volatile than Akero Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest  2,734  in Akero Therapeutics on September 13, 2024 and sell it today you would earn a total of  169.00  from holding Akero Therapeutics or generate 6.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Agios Pharm  vs.  Akero Therapeutics

Agios Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Akero Therapeutics

Risk-Adjusted Performance

3 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Agios Pharm and Akero Therapeutics

The main advantage of trading using opposite Agios Pharm and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.

The idea behind Agios Pharm and Akero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.